dc.contributor.author | Ackermann, Deonna M. | |
dc.contributor.author | Smit, Amelia K. | |
dc.contributor.author | Janda, Monika | |
dc.contributor.author | van Kemenade, Cathelijne H. | |
dc.contributor.author | Dieng, Mbathio | |
dc.contributor.author | Morton, Rachael L. | |
dc.contributor.author | Turner, Robin M. | |
dc.contributor.author | Cust, Anne E. | |
dc.contributor.author | Irwig, Les | |
dc.contributor.author | Hersch, Jolyn K. | |
dc.contributor.author | Guitera, Pascale | |
dc.contributor.author | Soyer, H. Peter | |
dc.contributor.author | Mar, Victoria | |
dc.contributor.author | Saw, Robyn P.M. | |
dc.contributor.author | Low, Donald | |
dc.contributor.author | Low, Cynthia | |
dc.contributor.author | Drabarek, Dorothy | |
dc.contributor.author | Espinoza, David | |
dc.contributor.author | Emery, Jon | |
dc.contributor.author | Murchie, Peter | |
dc.contributor.author | Thompson, John F. | |
dc.contributor.author | Scolyer, Richard A. | |
dc.contributor.author | Azzi, Anthony | |
dc.contributor.author | Lilleyman, Alister | |
dc.contributor.author | Bell, Katy J.L. | |
dc.date.accessioned | 2021-05-26T08:54:01Z | |
dc.date.available | 2021-05-26T08:54:01Z | |
dc.date.issued | 2021-05-04 | |
dc.identifier.citation | Ackermann , D M , Smit , A K , Janda , M , van Kemenade , C H , Dieng , M , Morton , R L , Turner , R M , Cust , A E , Irwig , L , Hersch , J K , Guitera , P , Soyer , H P , Mar , V , Saw , R P M , Low , D , Low , C , Drabarek , D , Espinoza , D , Emery , J , Murchie , P , Thompson , J F , Scolyer , R A , Azzi , A , Lilleyman , A & Bell , K J L 2021 , ' Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial ' , Trials , vol. 22 , no. 1 , 324 . https://doi.org/10.1186/s13063-021-05231-7 | en |
dc.identifier.issn | 1745-6215 | |
dc.identifier.other | PURE: 193911993 | |
dc.identifier.other | PURE UUID: 814be9a5-5f64-47ee-9995-23dcc39b07cf | |
dc.identifier.other | Scopus: 85105502711 | |
dc.identifier.other | PubMed: 33947444 | |
dc.identifier.other | ORCID: /0000-0001-9968-5991/work/95223184 | |
dc.identifier.other | WOS: 000656359100003 | |
dc.identifier.uri | https://hdl.handle.net/2164/16541 | |
dc.description | This research project is funded by a National Health and Medical Research Council (NHMRC) Project grant (#1163054). The funder had no role in the design of the study and will have no role in the collection, analysis, and interpretation of the data; the writing of the report; or the decision to submit the report for publication. Funding Information: AEC is funded by a Career Development Fellowship from the National Health and Medical Research Council (NHMRC; 1147843). JFT is a recipient of an NHMRC Program Grant (1093017). RPMS is supported by Melanoma Institute Australia. RAS is supported by a NHMRC Program Grant and Practitioner Fellowship. For RAS, support from the from colleagues at Melanoma Institute Australia, Royal Prince Alfred Hospital and NSW Health Pathology is also gratefully acknowledged. RLM is supported with an NHMRC Investigator grant (1194703) and a University of Sydney Robinson Fellowship. HPS holds an NHMRC MRFF Next Generation Clinical Researchers Program Practitioner Fellowship (APP1137127). JH is supported by an NHMRC Early Career Fellowship (1112509). KB is supported by an NHMRC Investigator Grant (1174523) and a University of Sydney Research Accelerator (SOAR) Prize. | en |
dc.format.extent | 18 | |
dc.language.iso | eng | |
dc.relation.ispartof | Trials | en |
dc.rights | This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | Cancer surveillance | en |
dc.subject | Early detection of cancer | en |
dc.subject | Health services research | en |
dc.subject | Melanoma | en |
dc.subject | Randomised controlled trial | en |
dc.subject | Self-examination | en |
dc.subject | Teledermoscopy | en |
dc.subject | Telehealth | en |
dc.subject | R Medicine | en |
dc.subject | Medicine (miscellaneous) | en |
dc.subject | Pharmacology (medical) | en |
dc.subject | Other | en |
dc.subject | 1147843 | en |
dc.subject | 1163054 | en |
dc.subject | 1093017 | en |
dc.subject | 1194703 | en |
dc.subject | APP1137127 | en |
dc.subject | 1174523 | en |
dc.subject | Supplementary Information | en |
dc.subject.lcc | R | en |
dc.title | Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Centre for Health Data Science | en |
dc.contributor.institution | University of Aberdeen.Clinical Medicine | en |
dc.contributor.institution | University of Aberdeen.Data Safe Haven | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1186/s13063-021-05231-7 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85105502711&partnerID=8YFLogxK | en |
dc.identifier.vol | 22 | en |
dc.identifier.iss | 1 | en |